주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
6,352 )
기사목록 보기 형태
제목형
요약형
포토형
Korean authorities ramp up support for foreign victims in Itaewon crush
Lee Han-soo, Marianne Chang
2022.10.31 14:50
Multimodal treatment key for long-term seizure-free outcomes in LGS patients
Marianne Chang
2022.10.31 13:46
In ‘Itaewon disaster,' reality was different from manuals
Koh Jung Min
2022.10.31 12:11
Psychiatrists urge people not to spread Itaewon crush video
Kim Yoon-mi
2022.10.30 15:48
'Preventing 19A serotype important in pediatric pneumococcal vaccines’
Marianne Chang
2022.10.29 07:00
OliPass receives $3 million upfront from Vanda Pharmaceutical for RNA-based treatment
Lee Han-soo
2022.10.28 17:11
Government urges booster vaccination for high-risk groups
Lee Han-soo
2022.10.28 16:33
In some Asian countries, telemedicine is ‘not optional but compulsory’
Koh Jung Min
2022.10.28 16:04
Syntekabio launches AI new drug cloud platform service
Marianne Chang
2022.10.28 15:54
FDA starts reviewing Hugel's biologics license application for BTX
Lee Han-soo
2022.10.28 14:37
AITRICS wins nod for emergency predicting solution
Park Gi-taek
2022.10.28 13:05
Promotion of Nursing Act will set global model, ICN official says
Koh Jung Min
2022.10.28 11:40
처음
이전
이전
이전
311
312
313
314
315
316
317
318
319
320
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기